← Open Payments lookup

KELLY ROBERTS: Open Payments

NPI 1699382465 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,523 in 52 payments from 21 companies in 2025. Trend: 2023 $277 · 2024 $863 · 2025 $1,523

Food & beverage: $1,523
CompanyPaymentsAmount
Novo Nordisk Inc8$334
Dexcom, Inc.12$266
Averitas Pharma Inc.3$140
Tandem Diabetes Care, Inc.1$101
Amgen Inc.5$87
Abbott Laboratories3$87
Insulet Corporation1$80
KYOWA KIRIN, INC.2$56
Boehringer Ingelheim Pharmaceuticals, Inc.3$52
Soleno Therapeutics, Inc.2$48

Products named: Dexcom G6 Transmitter, Wegovy, QUTENZA, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, Omnipod, Ozempic, JARDIANCE.

Industry payments across NV — which companies pay providers there.